Ketoconazole Pricing Report 2024​: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data

Ketoconazole Pricing Report 2024​: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data

Report Format: PDF+Excel | Report ID: SR112024A22909
Buy Now

Ketoconazole Prices June 2023

Product
Category Region Price
Ketoconazole Pharma API USA 145,981 USD/MT
Ketoconazole Pharma API China 135,556 USD/MT
Ketoconazole Pharma API Germany 146,987 USD/MT


In the second quarter of 2023, the price of the ketoconazole in the United States reached 145,981 USD/MT by June. Similarly, in China the ketoconazole prices hit 135,556 USD/MT in the same month. Germany also saw ketoconazole prices reaching 146,987 USD/MT during Q2 2023.

Ketoconazole Price Trend, Market Analysis, and News

IMARC’s newly published report, titled “Ketoconazole Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data,” offers an in-depth analysis of ketoconazole pricing, covering an analysis of global and regional market trends and the critical factors driving these price movements.

It encompasses an in-depth review of spot price of ketoconazole at major ports, a breakdown of prices including Ex Works, FOB, and CIF, alongside a region-wise dissection of ketoconazole price trend across North America, Europe, Asia Pacific, Latin America, the Middle East and Africa.

The report examines the elements influencing ketoconazole price fluctuations, such as changes in raw material costs, supply-demand dynamics, geopolitical factors, and industry-specific developments. Additionally, it integrates the latest market news, providing stakeholders with up-to-date information on market shifts, regulatory changes, and technological advancements, thereby offering a comprehensive overview that aids in strategic decision-making and forecasting.

Ketoconazole Price Trend

Ketoconazole Market Analysis

The global ketoconazole market size reached US$ 106.2 Million in 2023. By 2032, IMARC Group expects the market to reach US$ 139.8 Million, at a projected CAGR of 3.10% during 2023-2032.

  • The ketoconazole market is mainly driven by the rising prevalence of fungal infections across the world. This rise in mainly due to the overuse of antibiotics, which can disrupt the natural balance of microorganisms, creating an environment conducive to fungal growth. According to a report published by the Lancet, the estimates of fungal disease incidence and mortality data derived from data from 120+ countries show over 6.5 million invasive fungal infections and 3.8 million deaths annually. Aspergillosis, candidiasis, and other fungal infections contribute significantly to this burden, with approximately 68% of deaths directly attributed to these infections. Moreover, the use of immunosuppressive drugs in patients with organ transplants or autoimmune disease weakens the immune system, which makes individuals more susceptible to fungal infections. Due to the rising prevalence of fungal infections, the demand for antifungal treatments like ketoconazole is on the rise, thereby driving its market growth.
  • The rising incidence of chronic disease like diabetes and cancer is significantly contributing to the antifungal treatments like ketoconazole. Patients with diabetes are more vulnerable to fungal infections because of compromised immune systems and higher blood sugar levels. Cancer patients undergoing chemotherapy or radiation therapy often experience weakened immune systems, which makes them more suspectable to fungal infections. According to a report published by the World Health Organization, cardiovascular diseases cause most NCD deaths annually, at 17.9 million. This is followed by cancer (9.3 million), chronic respiratory disease (4.1 million), and diabetes (2 million, including deaths caused by kidney disease). These chronic conditions necessitate effective antifungal treatments to manage and prevent infections, hence driving the ketoconazole market growth.
  • Government initiatives and support mainly focused on improving infrastructure and increased accessibility for medications are important in supporting the market growth for ketoconazole. These initiatives generally include funding for healthcare services, subsidizing medications, and enhancing availability of essential drugs in remote and underserved areas. Ayushman Bharat is a flagship initiative which provides health insurance coverage to over 100 million vulnerable families in India, with coverage of up to INR 5,00,000 per family per year. This initiative aims to reduce the financial burden during medical emergencies and minimize out of pocket expenses. Over 87,000 crores have been secured under Indian citizens’ savings along with 5 Cr+ plus hospital admissions till now. Moreover, public health campaigns aimed at educating public about the importance of treating fungal infections also contribute to the increased awareness and usage of ketoconazole, further propelling its market growth.

Ketoconazole News

The report covers the latest developments, updates, and trends impacting the global ketoconazole market, providing stakeholders with timely and relevant information. This segment covers a wide array of news items, including the inauguration of new production facilities, advancements in ketoconazole production technologies, strategic market expansions by key industry players, and significant mergers and acquisitions that impact the ketoconazole price trend.

Latest developments in the ketoconazole industry:

  • In 2024, Johnson & Johnson announced the acquisition of Proteologix, Inc., a biotechnology company, for $850 million in cash. This move will expand J&J's portfolio to include bispecific antibodies targeting immune-mediated diseases like atopic dermatitis and asthma.
  • In 2024, LGM Pharma announced a significant expansion and investment in its Analytical Testing Services (ATS) and the addition of suppository manufacturing capabilities to its contract development and manufacturing (CDMO) portfolio. The expansion aims to provide greater flexibility and agility to address evolving needs. The company's ATS now includes comprehensive method development and validation services, stability testing, and state-of-the-art instrumentation. The new suppository manufacturing capabilities aim to meet increasing market demand, especially in women's health products.

Product Description

Ketoconazole is a synthetic antifungal medication primarily used to treat fungal infections. It belongs to the class of drugs known as azole antifungals and works by inhibiting the synthesis of ergosterol, a vital component of fungal cell membranes, thereby disrupting cell membrane formation and leading to the death of the fungal cell. Ketoconazole can be administered orally or applied topically, depending on the location and severity of the infection. In its oral form, it's used to treat systemic fungal infections including candidiasis, chronic mucocutaneous candidiasis, and more severe endemic mycoses such as blastomycosis, coccidioidomycosis, and histoplasmosis. Topically, it can be found in shampoos, creams, and foams for the treatment of skin infections such as athlete's foot, ringworm, and dandruff. Due to potential side effects, including liver damage and interactions with other medications, ketoconazole's use is generally reserved for cases where other antifungal treatments are not suitable.

Regional Coverage

The report provides a detailed analysis of the ketoconazole market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of ex-works, FOB, and CIF prices, as well as the key factors influencing the ketoconazole price trend. 

Global Ketoconazole Price

The report offers a holistic view of the global ketoconazole pricing trends in the form of ketoconazole price charts, reflecting the worldwide interplay of supply-demand balances, international trade policies, and overarching economic factors that shape the market on a macro level. This comprehensive analysis not only highlights current price of ketoconazole but also provides insights into historical price trends, enabling stakeholders to understand past fluctuations and their underlying causes.

The report also delves into price forecast models, projecting future price movements based on a variety of indicators such as expected changes in supply chain dynamics, anticipated policy shifts, and emerging market trends. By examining these factors, the report equips industry participants with the necessary tools to make informed strategic decisions, manage risks, and capitalize on market opportunities. Furthermore, it includes a detailed ketoconazole demand analysis, breaking down regional variations and identifying key drivers specific to each geographic market, thus offering a nuanced understanding of the global pricing landscape.

Europe Ketoconazole Price

European ketoconazole prices are examined, highlighting the market-specific influences in the region, such as stringent environmental regulations, the competitive landscape, and import-export imbalances that significantly affect pricing structures.

This analysis can be extended to include detailed ketoconazole price information for a comprehensive list of countries.

Region Countries Covered
Europe Germany, France, United Kingdom, Italy,  Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal, and Greece, among other European countries.


North America Ketoconazole Price

The analysis of ketoconazole prices in North America delves into the regional industry dynamics, encompassing the impact of local production capacities and the trade flows between North America and other significant global markets.

Specific ketoconazole historical data within the United States and Canada can also be provided.

Region Countries Covered
North America United States and Canada


Middle East and Africa Ketoconazole Price

The report explores the ketoconazole pricing trends in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.

In addition to region-wise data, information on ketoconazole prices for countries can also be provided.

Region Countries Covered
Middle East & Africa Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco, among other Middle Eastern and African countries.


Asia Pacific Ketoconazole Price

The ketoconazole pricing trends in Asia Pacific are examined, reflecting the role of the region as a major global production hub and consumer market, with price dynamics heavily influenced by supply chain efficiencies, regional demand surges, and policy shifts in major economies.

This ketoconazole price analysis can be expanded to include a comprehensive list of countries within the region.

Region Countries Covered
Asia Pacific China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand, among other Asian countries.


Latin America Ketoconazole Price

The analysis of ketoconazole prices in Latin America provides a detailed overview, reflecting the unique market dynamics in the region influenced by economic policies, industrial growth, and trade frameworks.

This comprehensive review can be extended to include specific countries within the region.

Region Countries Covered
Latin America Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru, among other Latin American countries.


Report Coverage

Key Attributes Details
Product Name Ketoconazole
Report Features Exploration of Historical Trends and Market Outlook, Industry Demand, Industry Supply, Gap Analysis, Challenges, Ketoconazole Price Analysis, and Segment-Wise Assessment.
Currency/Units US$ (Data can also be provided in local currency) or Metric Tons
Region/Countries Covered The current coverage includes analysis at the global and regional levels only. 
 
Based on your requirements, we can also customize the report and provide specific information for the following countries: 
 
Asia Pacific: China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand*
 
Europe: Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal and Greece* 
 
North America: United States and Canada

Latin America: Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru*

Middle East & Africa: Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco*

*The list of countries presented is not exhaustive. Information on additional countries can be provided if required by the client.
Information Covered for Key Suppliers
  • Company Overview
  • Business Description
  • Product Portfolio
  • Recent Trends and Developments
Customization Scope The report can be customized as per the requirements of the customer
Report Price and Purchase Option

Plan A: Monthly Updates - Annual Subscription

  • Scope
    • Historical Data for the Current Month
    • Forecast for Next Month
  • Total Deliverables Per Year: 12 (One Per Month)
  • Includes: One PDF and Excel datasheet per month, Post Purchase Analyst Support throughout the year

Plan B: Quarterly Updates - Annual Subscription

  • Scope
    • Historical Data for the Current Quarter
    • Forecast for Next Quarter
  • Total Deliverables Per Year: 4 (One Per Quarter)
  • Includes: One PDF and Excel datasheet per Quarter, Post Purchase Analyst Support throughout the year

Plan C: Biannually Updates - Annual Subscription

  • Scope
    • Historical Data for the Current Half
    • Forecast for the Next Half
  • Total Deliverables Per Year: 2 (One Per 6 Months)
  • Includes: One PDF and Excel datasheet per Half, Post Purchase Analyst Support throughout the year  
Post-Sale Analyst Support  360-degree analyst support after report delivery
Delivery Format PDF and Excel through email (We can also provide the editable version of the report in PPT/Word format on special request) 


Key Benefits for Stakeholders:

  • IMARC’s report presents a detailed analysis of ketoconazole pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
  • The study examines factors affecting ketoconazole price trend, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
  • The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
  • IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights. The ketoconazole price charts ensure our clients remain at the forefront of the industry.

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Ketoconazole Pricing Report 2024​: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data
Purchase options
For 2 Deliverables, Billed Annually

For 4 Deliverables, Billed Annually

For 12 Deliverables, Billed Annually


Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More